How many kg is 75 lbs? Round to the nearest tenth.

A. Gram-negative bacteria have a thinner peptidoglycan layer compared to Gram-positive bacteria. The thicker peptidoglycan of Gram-positive bacteria is more easily targeted by certain antibiotics like penicillin.

B. Gram-negative bacteria have an outer membrane with lipopolysaccharides, which acts as a barrier to many antibiotics. This structural complexity often necessitates the use of antibiotics that can penetrate the outer membrane or have mechanisms to bypass this barrier.

C. Gram-negative bacteria are more prone to developing antibiotic resistance due to their outer membrane and efflux pumps. This complicates treatment decisions rather than simplifying them, requiring vigilance in antibiotic selection and monitoring.

D. While Gram-negative bacteria do have a thinner peptidoglycan layer, their outer membrane protects them from many antibiotics, so they are not inherently more susceptible. Treatment must consider this additional barrier to ensure efficacy.

A. The client has less itching.: Itching in liver disease is caused by bile salt accumulation under the skin and is not directly affected by lactulose. Improvement in pruritus is more closely related to bile acid–binding agents rather than ammonia-reducing therapy.

B. The client is having less bowel movements.: Lactulose works by increasing bowel movements to promote the excretion of ammonia from the body. Fewer bowel movements would actually suggest reduced medication effectiveness in managing hepatic encephalopathy.

C. The client's ammonia levels have decreased.: Lactulose reduces blood ammonia levels by trapping ammonia in the colon and enhancing its excretion through feces. A decrease in serum ammonia reflects improved hepatic encephalopathy control.

D. The client has less pain and less jaundice.: Pain and jaundice in end-stage liver disease result from liver inflammation and bile obstruction, not elevated ammonia. Lactulose does not directly influence bilirubin metabolism or liver pain.